Inlecitug
Inlecitug is a chimeric monoclonal antibody targeting human KDR (kinase insert domain receptor) . Inlecitug specifically binds to KDR, blocking the binding of vascular endothelial growth factor (VEGF) to KDR and inhibiting angiogenesis, thus exerting antitumor activity. Inlecitug is promising for research of cancers[1].
Product Specifications
CAS Number
2997627-68-4
UNSPSC
12352203
Target
VEGFR
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
[Inlecitug]
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7137977 Inquire
Rabbit anti-Danio rerio (Zebrafish)(Brachydanio rerio) anks1b Polyclonal Antibody
Sign In for Pricing
View Details 
PLK1S1-6852M 50 µg
Recombinant Mouse PLK1S1 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details 
